VYD222
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VYD222, covering 2024-05-31 to 2024-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 [Phase 3]